KALV - KalVista Pharmaceuticals, Inc.
IEX Last Trade
8.5
-0.015 -0.176%
Share volume: 3,786
Last Updated: Fri 27 Dec 2024 07:29:49 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.10%
PREVIOUS CLOSE
CHG
CHG%
$8.52
-0.02
-0.18%
Summary score
25%
Profitability
25%
Dept financing
4%
Liquidity
75%
Performance
18%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2017 - 30-Sep-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.77%
Return on assets
-10.76%
Return on sales
-264.15%
Return on invested capital
112.02%
Total debt ratio
22.84%
Debt ratio change over timeo
0.87%
Current Ratio
7.39%
Quick Ratio
7.21%
Cash Position Ratio
6.17%
Short-term ratios 30-Sep-2020 - 30-Sep-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.9%
Return on assets
-15.74%
Return on sales
-234.21%
Return on invested capital
230.4%
Total debt ratio
11.55%
Debt ratio change over timeo
-0.84%
Current Ratio
9.53%
Quick Ratio
9.53%
Cash Position Ratio
7.49%
Last quarter ratios 30-Sep-2021
The data are presented for the financials results of the last quarter.
Return on equity
-17.16%
Return on assets
-19.12%
Return on sales
0%
Return on invested capital
356.82%
Total debt ratio
11.54%
Debt ratio change over time
-0.49%
Current Ratio
9.59%
Quick Ratio
9.59%
Cash Position Ratio
7.72%
Performance ratios (change over 4 years) 30-Sep-2017 - 30-Sep-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-161.44%
Return on assets
-133.68%
Return on sales
-1053.82%
Return on invested capital
132.17%
Total debt ratio
86.81%
Debt ratio change over time
0.87%
Current Ratio
16.22%
Quick Ratio
17.05%
Cash Position Ratio
13.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KALV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.77% | -7.69% | 14.61% | 8.01% |
| Return on assets | -10.76% | 3.29% | 3.68% | 6.04% |
| Return on sales | -264.15% | 30% | 39.26% | 38.23% |
| Return on invested capital | 112.02% | 4.43% | 6.72% | 20.12% |
| Profitability | 25% | 34% | 67% | 68% |
| Total debt ratio | 22.84% | 101.02% | 81.85% | 29.04% |
| Debt ratio change over time | 0.87% | 264.69% | 10.39% | 1.23% |
| Dept financing | 6% | 50% | 21% | 7% |
| Current Ratio | 9.53% | 0.9% | 1.61% | 3.51% |
| Quick Ratio | 9.53% | 0.79% | 1.3% | 2.89% |
| Cash Position Ratio | 7.49% | 0.33% | 0.79% | 1.26% |
| Liquididy | 75% | 11% | 20% | 29% |
| Short-term ratios | KALV | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.9% | 13.8% | 15.84% | 12.42% |
| Return on assets | -15.74% | 2.99% | 3.54% | 8.7% |
| Return on sales | -234.21% | 32.39% | 34.36% | 50.95% |
| Return on invested capital | 230.4% | 2.03% | 5.06% | 36.47% |
| Profitability | 25% | 46% | 53% | 74% |
| Total debt ratio | 11.55% | 91.15% | 85.92% | 31.26% |
| Debt ratio change over time | -0.84% | 184.38% | 21.74% | 1.39% |
| Dept financing | 3% | 50% | 27% | 9% |
| Current Ratio | 9.53% | 0.9% | 1.61% | 3.51% |
| Quick Ratio | 9.53% | 0.79% | 1.3% | 2.89% |
| Cash Position Ratio | 7.49% | 0.33% | 0.79% | 1.26% |
| Liquididy | 75% | 6% | 10% | 21% |